Descriptive observational study on the use of virtual reality in patients with inflammatory bowel disease undergoing biological treatment.

IF 2.2 4区医学 Q3 GASTROENTEROLOGY & HEPATOLOGY

Gastroenterologia y hepatologia Pub Date : 2024-08-22 DOI:10.1016/j.gastrohep.2024.502236

Raúl José Díaz Molina, Carlos Comesaña Castellar, Joan Crespí Rigo, Catalina Radu Tomsa, Patricia Quesada Bauzá, Isabel Porcel Corra, Pau Sendra Rumbeu, Vanesa Royo Escosa, María Dolores Herrera González, Eva Puchol Segarra, Daniel Ginard Vicens

{"title":"Descriptive observational study on the use of virtual reality in patients with inflammatory bowel disease undergoing biological treatment.","authors":"Raúl José Díaz Molina, Carlos Comesaña Castellar, Joan Crespí Rigo, Catalina Radu Tomsa, Patricia Quesada Bauzá, Isabel Porcel Corra, Pau Sendra Rumbeu, Vanesa Royo Escosa, María Dolores Herrera González, Eva Puchol Segarra, Daniel Ginard Vicens","doi":"10.1016/j.gastrohep.2024.502236","DOIUrl":null,"url":null,"abstract":"Background: Virtual reality (VR) is a neurosensory experience in which simulated spaces a person has the sensation of being able to function within them. Some patients with inflammatory bowel disease (IBD) receive intravenous biological treatments in an Adult Day Hospital (ADH) regime. VR has been used in some fields of medicine, demonstrating its usefulness in reducing negative symptoms. However, we do not have any literature showing the applicability in real clinical practice of VR in IBD.Methods: Descriptive observational pilot study based on an initial cohort of 87 patients that were obtained from the ADH of the IBD Unit. Satisfaction and acceptance of VR through the use of 3D glasses and the reduction of negative symptoms during intravenous biological treatment in patients with IBD in ADH have been assessed.Results: 43 patients (52.4%) used VR and completed the study. In the comparative analysis of the results of the questionnaires before and after the use of VR, a statistically significant improvement was observed in the patients' view on the ability of VR to achieve a reduction in stress (65% patients improve; p: 0.0021) and pain (VAS, 54% p. improve; p<0.05) during treatment. Likewise, with the applicability of VR in other areas of medicine (53%; p: 0.05) and with the possibility of improving well-being during the stay in the ADH (56%; p: 0.0014). No side effects were reported with the use of the 3D glasses.Conclusions: VR is a useful complementary tool to improve the stay of patients with IBD on ADH during intravenous treatment.","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":" ","pages":"502236"},"PeriodicalIF":2.2000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterologia y hepatologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.gastrohep.2024.502236","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Virtual reality (VR) is a neurosensory experience in which simulated spaces a person has the sensation of being able to function within them. Some patients with inflammatory bowel disease (IBD) receive intravenous biological treatments in an Adult Day Hospital (ADH) regime. VR has been used in some fields of medicine, demonstrating its usefulness in reducing negative symptoms. However, we do not have any literature showing the applicability in real clinical practice of VR in IBD.

Methods: Descriptive observational pilot study based on an initial cohort of 87 patients that were obtained from the ADH of the IBD Unit. Satisfaction and acceptance of VR through the use of 3D glasses and the reduction of negative symptoms during intravenous biological treatment in patients with IBD in ADH have been assessed.

Results: 43 patients (52.4%) used VR and completed the study. In the comparative analysis of the results of the questionnaires before and after the use of VR, a statistically significant improvement was observed in the patients' view on the ability of VR to achieve a reduction in stress (65% patients improve; p: 0.0021) and pain (VAS, 54% p. improve; p<0.05) during treatment. Likewise, with the applicability of VR in other areas of medicine (53%; p: 0.05) and with the possibility of improving well-being during the stay in the ADH (56%; p: 0.0014). No side effects were reported with the use of the 3D glasses.

Conclusions: VR is a useful complementary tool to improve the stay of patients with IBD on ADH during intravenous treatment.

查看原文本刊更多论文

关于在接受生物治疗的炎症性肠病患者中使用虚拟现实技术的描述性观察研究。

背景介绍虚拟现实（VR）是一种神经感觉体验，在模拟的空间中，人可以感觉到自己在其中活动。一些炎症性肠病（IBD）患者在成人日间医院（ADH）接受静脉生物治疗。虚拟现实技术已被用于某些医学领域，证明其在减轻负面症状方面非常有用。然而，我们还没有任何文献显示 VR 在 IBD 实际临床实践中的适用性：方法：描述性观察试点研究，基于从肠道疾病科 ADH 获得的 87 名患者的初始队列。研究评估了ADH中的IBD患者通过使用3D眼镜对VR的满意度和接受度，以及在静脉生物治疗过程中减少负面症状的情况：结果：43 名患者（52.4%）使用了 VR 并完成了研究。在对使用 VR 前后的问卷结果进行比较分析时，发现患者对 VR 能够减轻压力（65% 的患者有所改善；P：0.0021）和疼痛（VAS，54% 的患者有所改善；P：0.0021）的看法有了显著改善：VR 是一种有用的辅助工具，可改善接受 ADH 静脉注射治疗的 IBD 患者的住院情况。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gastroenterologia y hepatologia GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

1.50

自引率

10.50%

发文量

147

审稿时长

48 days

期刊介绍： Gastroenterology and Hepatology is the first journal to cover the latest advances in pathology of the gastrointestinal tract, liver, pancreas, and bile ducts, making it an indispensable tool for gastroenterologists, hepatologists, internists and general practitioners.